CollPlant Biotechnologies (CLGN) Expected to Announce Quarterly Earnings on Wednesday

CollPlant Biotechnologies (NASDAQ:CLGN) will likely be posting its quarterly earnings results before the market opens on Wednesday, March 26th. Analysts expect CollPlant Biotechnologies to post earnings of ($0.42) per share and revenue of $0.36 million for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

CollPlant Biotechnologies Trading Up 0.3 %

CLGN stock opened at $3.11 on Tuesday. The stock has a market cap of $35.63 million, a PE ratio of -2.02 and a beta of 1.07. CollPlant Biotechnologies has a 12 month low of $3.00 and a 12 month high of $6.75. The company has a 50-day moving average price of $3.55 and a 200 day moving average price of $3.99.

Wall Street Analyst Weigh In

Several brokerages have issued reports on CLGN. D. Boral Capital restated a “buy” rating and set a $14.00 target price on shares of CollPlant Biotechnologies in a research report on Wednesday, February 12th. HC Wainwright reissued a “buy” rating and set a $11.00 price target on shares of CollPlant Biotechnologies in a research note on Friday, November 29th.

CollPlant Biotechnologies Company Profile

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology.